We are live on ! Find out more
VOR icon

Vor Biopharma
VOR

71 hedge funds and large institutions have $54.5M invested in Vor Biopharma in 2024 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 17 increasing their positions, 19 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 20

4% more funds holding

Funds holding: 68 → 71 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.33% less ownership

Funds ownership: 4.32% → 3.99% (-0.33%)

11% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 19

61% less capital invested

Capital invested by funds: $140M → $54.5M (-$85.2M)

Holders
71
Holders Change
+3
Holders Change %
+4.41%
% of All Funds
1.03%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
23
Increased
17
Reduced
19
Closed
20
Calls
$16K
Puts
–
Net Calls
+$16K
Net Calls Change
-$21K

Top Buyers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
+$456K
2
Millennium Management
Millennium Management
New York
+$374K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$357K
4
Jane Street
Jane Street
New York
+$328K
5
Renaissance Technologies
Renaissance Technologies
New York
+$260K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$2.83M
2
WP
Woodline Partners
California
-$2.63M
3
AG
Artal Group
Luxembourg
-$2.37M
4
LCM
Laurion Capital Management
New York
-$1.06M
5
State Street
State Street
Massachusetts
-$876K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
76
American International Group
New York
– -$44.6K -940 Closed
XT
77
XTX Topco
Cayman Islands
– -$44.2K -932 Closed
Invesco
78
Invesco
Georgia
– -$41.2K -869 Closed
Walleye Capital
79
Walleye Capital
New York
– -$39.2K -828 Closed
VOYA Investment Management
80
VOYA Investment Management
Georgia
– -$34.8K -733 Closed
Wells Fargo
81
Wells Fargo
California
– -$32K -674 Closed
SG Americas Securities
82
SG Americas Securities
New York
– -$31K -659 Closed
California State Teachers Retirement System (CalSTRS)
83
California State Teachers Retirement System (CalSTRS)
California
– -$9.09K -192 Closed
Legal & General Group
84
Legal & General Group
United Kingdom
– -$8.6K -181 Closed
AIP
85
Ameritas Investment Partners
Nebraska
– -$7.37K -156 Closed
Comerica Bank
86
Comerica Bank
Texas
– -$6.31K -133 Closed
Lazard Asset Management
87
Lazard Asset Management
New York
– -$2.33K -72 -96%
AB
88
Amalgamated Bank
New York
– -$3K -64 Closed
Royal Bank of Canada
89
Royal Bank of Canada
Ontario, Canada
– -$2K -44 Closed
Nisa Investment Advisors
90
Nisa Investment Advisors
Missouri
– -$107 -2 Closed
AWM
91
Avior Wealth Management
Nebraska
– -$14 – –
1 2 3
4

VOR Hedge Fund Activity: Q2 2024 in Review

71 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Vor Biopharma (VOR) for Q2 2024, worth a combined $54.5M — down 61% from $140M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new VOR positions and 20 closed out — a net gain of 3 holders — while 17 added to existing stakes and 19 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $456K. The largest seller was BlackRock, cutting an estimated $2.83M.

  • 71 institutional investors held Vor Biopharma (VOR) as of Q2 2024, up from 68 in Q1 2024.
  • Funds reported $54.5M of Vor Biopharma stock for Q2 2024, down 61% quarter-over-quarter.
  • 23 funds opened new Vor Biopharma positions in Q2 2024 and 20 closed out, a net change of +3 holders.
  • The largest Vor Biopharma buyer in Q2 2024 was Goldman Sachs, an estimated $456K added.
  • The largest Vor Biopharma seller in Q2 2024 was BlackRock, an estimated $2.83M sold.

Based on aggregated 13F filings for Q2 2024.